SOLENO THERAPEUTICS INC·4

Nov 19, 6:49 PM ET

Norrett Kevin 4

4 · SOLENO THERAPEUTICS INC · Filed Nov 19, 2025

Insider Transaction Report

Form 4
Period: 2025-11-17
Norrett Kevin
Chief Business Officer
Transactions
  • Award

    Common Stock

    2025-11-17+14,28614,286 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2025-11-17+64,28664,286 total
    Exercise: $47.25Exp: 2035-11-17Common Stock (64,286 underlying)
Footnotes (2)
  • [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. One-half of the RSUs shall vest on November 17, 2026 and one third of the remaining RSUs shall vest each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
  • [F2]One-fourth of the shares subject to the option shall vest on November 17, 2026 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

Documents

1 file
  • 4
    form4-11192025_111147.xmlPrimary